Peripheral amyloid levels present gender differences associated with aging in AβPP/PS1 mice

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Alzheimer's disease (AD) is characterized by amyloid-β (Aβ) peptide accumulation.
• Understanding the progression of amyloidosis is crucial for developing effective treatments.
• Gender-specific differences in AD progression are not fully understood.

Purpose of the Study:

• To investigate the sex-specific differences in amyloidosis progression in a mouse model of Alzheimer's disease.
• To analyze the changes in peripheral amyloid-β peptide levels (Aβ40 and Aβ42) in male and female AβPP/PS1 transgenic mice over time.
• To determine if aging affects amyloid accumulation differently between sexes.

Main Methods:

• Utilized AβPP/PS1 transgenic mice, a common model for studying Alzheimer's disease.
• Measured peripheral levels of amyloid-β peptides (Aβ40 and Aβ42) in plasma.
• Compared amyloid levels between male and female mice at different age points.

Main Results:

• Peripheral amyloid levels (Aβ40 and Aβ42) remained unchanged in both sexes until 9 months of age.
• After 9 months, female mice showed increased plasma amyloid levels.
• Conversely, male mice exhibited decreased plasma amyloid levels after 9 months of age.

Conclusions:

• Aging impacts amyloid accumulation differently in male and female AβPP/PS1 mice.
• These sex-specific changes in peripheral amyloidosis suggest potential gender differences in Alzheimer's disease progression.
• Findings may inform the development of gender-specific therapeutic strategies for Alzheimer's disease.